MTLS MATERIALISE NV
Price Chart
Executive Summary
Materialise reported stable Q1 2026 revenue of €66.3M (flat YoY) but swung to a net profit of €1.8M from a loss of €0.5M, driven by margin expansion and cost control. The company also announced the transfer of its eyewear business to management (with expected Q2 impairment charges) and reaffirmed full-year guidance. The Medical segment grew 6.7%, offset by declines in Software (-1.4%) and Manufacturing (-8.1%).
Actionable Insight
Monitor Q2 2026 for impairment charges related to the eyewear transfer and any impact on guidance. The Medical segment's continued growth and margin expansion are positive, but Manufacturing weakness and flat total revenue warrant caution. Watch for management's commentary on the conference call for segment trends.
Key Facts
- Q1 2026 total revenue flat at €66,276k vs €66,379k YoY
- Net profit of €1,820k vs net loss of €535k YoY
- Adjusted EBIT rose to €2,470k from €646k YoY
- Medical segment revenue +6.7%, Software -1.4%, Manufacturing -8.1%
- Gross margin improved to 57.2% from 55.3% YoY
- Net cash position increased €2,021k to €72,826k
- Transferred eyewear business to management; expects Q2 2026 impairment charges
- Reaffirmed FY2026 guidance: revenue €273M-€283M, Adjusted EBIT €10M-€12M
Financial Impact
Net profit improved by ~€2.4M YoY; impairment charges expected in Q2 2026 (undisclosed amount)
Risk Factors
- Impairment charges in Q2 2026 from eyewear transfer could weigh on earnings
- Manufacturing segment revenue declining 8.1% may signal further weakness
- Macroeconomic and geopolitical uncertainty may persist, impacting growth
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-057219 |
| Document: tm2613875d1_6k.htm | 0001104659-26-057219 |
| Document: 0001104659-26-057219-index-headers.html | 0001104659-26-057219 |
| Document: 0001104659-26-057219-index.html | 0001104659-26-057219 |
| Document: 0001104659-26-057219.txt | 0001104659-26-057219 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 1, 2026
11d ago
|
6-K
| $6.89 $6.61 | ▼ −4.06% | ▼ −3.37% | $6.66 (−3.34%) |
|
May 18, 2026
25d ago
|
6-K
| $5.56 $5.66 | ▲ +1.80% | ▲ +0.76% | $6.66 (+19.78%) |
|
May 15, 2026
28d ago
|
6-K
| $5.61 $5.56 | ▼ −0.89% | ▼ −0.24% | $6.66 (+18.72%) |
|
May 8, 2026
5w ago
|
6-K
| $5.41 $5.47 | ▲ +1.11% | ▲ +0.88% | $6.66 (+23.11%) |
|
May 7, 2026
5w ago
|
6-K
| $5.41 $5.47 | ▲ +1.11% | ▲ +0.88% | $6.66 (+23.11%) |
|
Apr 27, 2026
6w ago
|
6-K
| $5.30 $5.25 | ▼ −0.94% | ▼ −0.93% | $6.66 (+25.66%) |
|
Apr 23, 2026
7w ago
|
6-K
| $5.21 $5.31 | ▲ +1.92% | ▲ +1.76% | $6.66 (+27.83%) |
|
Apr 23, 2026
7w ago
|
20-F
| $5.21 $5.31 | ▲ +1.92% | ▲ +1.76% | $6.66 (+27.83%) |
|
Apr 20, 2026
7w ago
|
6-K
| $5.39 $5.46 | ▲ +1.30% | ▲ +0.28% | $6.66 (+23.56%) |
|
Apr 13, 2026
8w ago
|
6-K
| $5.20 $5.31 | ▲ +2.12% | ▲ +1.34% | $6.66 (+28.08%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access